Rubitection's early skin assessment and care management system has board applications in the $339 billion skin health market which includes dermatological conditions (e.g. rosacea, dermatitis, etc), plastic surgery, wound care (e.g. diabetic foot ulcers, and bedsores), and cosmetics. Our solution addresses the unreliability of visual subjective skin inspections that can lead to misdiagnosis, costly frustration with "wait and see" medical recommendations, and deaths from missed complications with infected wounds. Rubitection's solution, the Rubitect Assessment System, provides an affordable probe to reliably measure and assess the biometrics of the skin. It also includes an AI based software to support risk tracking and care management to enabling personalized care and improved patient outcomes. Our system can use used by a consumer or medical professional with minimal training. It is reliable on all skin tones, even dark skin where the skin color can mask diagnostic cues. Rubitection's initial market targets an untapped $4.1 billion US healthcare market by solving an $11 billion healthcare problem: early bedsore detection. Bedsores, also known as pressure injuries, affect 2.3 million each year killing 60,000. If caught early they can be prevented. Subjective skin inspections make early detection unreliable. The Rubitect Assessment System solves this problem. When used in a hospital, nursing home, or home care setting the Rubitect Assessment System can help save patient's lives, reduce associated cost, and provide objective data to support customized care. To enter the wound care market, we will partner with strategic existing sales and distribution partners like 3M, HillRom and Medline. Two recurring revenue streams support sustain revenue generation. Through strategic partnerships we can grow to over $153 million in sales within 5 years of launching our product on the market. Our vision is to become the global standard tool for skin health assessment to improve the quality of care and eliminate health disparities. We believe no one should die from a bedsore, its preventable. The use of the RAS we can empower caregivers to keep their loved ones safe during the most vulnerable times of their life.